Showing 199–204 of 229 results
CAS code：341031-54-7
Indications:
Gastrointestinal stromal tumor (GIST) and advanced renal cell carcinoma.
Pharmacology:
A small molecule inhibitor of multiple receptor tyrosine kinases (RTKs), some of which are involved in tumor growth, pathological angiogenesis, and metastasis.
Chinese Name: TAK788
English Name: TAK-788
Purity: 99.0%
Product Category: Intermediate
Background Information:
On January 15, 2020, the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) announced that TAK-788, developed by Takeda, has received implicit clinical trial approval in China.
TAK-788 is a next-generation, potent, and selective small molecule tyrosine kinase inhibitor (TKI), specifically developed to treat non-small cell lung cancer (NSCLC) patients with EGFR exon 20 insertion mutations.
Keywords:
TAK788; TAK-788; AP 32788
Chinese Name: 三氟甘露糖
English Name: TATM
CAS Number: 92051-23-5
Purity: 99.0%
Product Category: Intermediate
Chinese Synonyms:
甘露糖三氟磺酸酯
1,3,4,6-四乙酰-2-三氟甲烷磺酰-β-D-吡喃甘露糖
1,3,4,6-O-四乙酰基-2-O-三氟甲磺酰基-β-D-吡喃甘露糖
四-邻-乙酰基-2-三氟甲烷-黄酰基吡喃甘露糖
English Synonyms:
BETA-D-Mannopyranose 1,3,4,6-tetraacetate 2-triflate
1,3,4,6-Tetra-O-acetyl-2-O-trifluoromethanesulfonyl-β-D-mannopyranose
1,3,4,6-Tetra-O-acetyl-2-O-trifluoromethylsulphonyl-β-D-mannopyranose
Mannose triflate
Molecular Formula: C₁₅H₁₉F₃O₁₂S
Molecular Weight: 480.36
EINECS Number: Not available
Structure File: Available as
92051-23-5.mol
Keywords:
92051-23-5; TATM; Mannose triflate; 三氟甘露糖; 甘露糖三氟磺酸酯